Is this you? Create Your Porfile
Avatar

Michael Firnges

Solvay

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael Firnges is active.

Explore More

Publication

Featured researches published by Michael Firnges.

Bioorganic & Medicinal Chemistry Letters | 2004

Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.

Alessio Innocenti; Michael Firnges; Jochen Antel; Michael Wurl; Andrea Scozzafava; Claudiu T. Supuran

Bioorganic & Medicinal Chemistry Letters | 2005

Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides

Alessio Innocenti; Michael Firnges; Jochen Antel; Michael Wurl; Andrea Scozzafava; Claudiu T. Supuran

Archive | 2007

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

Jochen Antel; Peter-Colin Gregory; Josephus H. M. Lange; Michael Firnges; Dania Reiche

Bioorganic & Medicinal Chemistry Letters | 2005

Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides

Alessio Innocenti; Jochen Antel; Michael Wurl; Daniela Vullo; Michael Firnges; Andrea Scozzafava; Claudiu T. Supuran

Archive | 2005

Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions

Michael Firnges; Peter-Colin Gregory; Jochen Antel; Josephus H. M. Lange; Harald Waldeck

Archive | 2005

Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions

Michael Firnges; Peter-Colin Gregory; Jochen Antel; Josephus H. M. Lange; Harald Waldeck

Archive | 2007

Use of CBx cannabinoid receptor modulators as potassium channel modulators

Jochen Antel; Peter-Colin Gregory; Josephus H. M. Lange; Michael Firnges; Dania Reiche

Archive | 2006

Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions

Jochen Antel; Uwe Schoen; Harald Waldeck; Michael Wurl; Michael Firnges; Dania Reiche; Peter-Colin Gregory

Archive | 2006

Method of using potassium channel inhibiting compounds

Jochen Antel; Peter-Colin Gregory; Michael Firnges; Dania Reiche

Archive | 2006

N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

Jochen Antel; Michael Firnges; Uwe Schoen; Harald Waldeck; Michael Wurl; Dania Reiche; Peter-Colin Gregory

Explore More

Collaboration

Dive into the Michael Firnges's collaboration.

Top Co-Authors
Avatar

Jochen Antel

University of Göttingen

View shared research outputs
Top Co-Authors
Avatar

Peter-Colin Gregory

Solvay

View shared research outputs
Top Co-Authors
Avatar

Dania Reiche

Solvay

View shared research outputs
Top Co-Authors
Avatar

Harald Waldeck

Solvay

View shared research outputs
Top Co-Authors
Avatar

Michael Wurl

Solvay

View shared research outputs
Top Co-Authors
Avatar

Uwe Schoen

Solvay

View shared research outputs
Top Co-Authors
Avatar

Holger Sann

Solvay

View shared research outputs
Top Co-Authors
Avatar

Josephus H. M. Lange

Solvay

View shared research outputs
Top Co-Authors
Avatar

Dania Reiche

Solvay

View shared research outputs
Top Co-Authors
Avatar

Daniel Jasserand

Solvay

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge